Vildagliptin (50mg) + Metformin (850mg)
Jalra-M 50mg/850mg Tablet is used in the treatment of type 2 diabetes.
1 Strip of 10 Tablet
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Jalra-M 50mg/850mg Tablet is to be taken with food.
Jalra-M 50mg/850mg Tablet may cause stomach upset if taken on empty stomach.
Jalra-M 50mg/850mg Tablet is a combination of two antidiabetic medicines: Metformin and Vildagliptin. Metformin is an anti-diabetic medication (biguanide). It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body"s sensitivity to insulin. Vildagliptin is a DPP-4 inhibitor which works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. This reduces both fasting and postmeal sugar levels. Together, they provide better control of blood sugar.
Related Warnings
Taking metformin with alcohol can cause lactic acidosis and you may experience malaise, respiratory distress, slow or irregular heartbeat, sleepiness, stomach upset, or other unusual symptoms.
Jalra-M 50mg/850mg Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
No information is available on the use of Jalra-M 50mg/850mg Tablet during lactation. Please consult your doctor.
Your ability to drive may be affected if your blood sugar is low or high. If this happens, do not drive.
Jalra-M 50mg/850mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Jalra-M 50mg/850mg Tablet may be needed. Please consult your doctor.
Jalra-M 50mg/850mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Jalra-M 50mg/850mg Tablet may be needed. Please consult your doctor.
Regular monitoring of liver function tests is recommended if you are taking this medicine. Use of $med_name is preferably not advised in patients with liver disease.
